Skip to main content

COSMETIC DERMATOLOGY

Jeuveau™

Jeuveau™

Overview

Juveau Before and After

Jeuveau, or “Newtox,” is an injectable neurotoxin similar in structure to BOTOX®. As the first new injectable treatment to hit the market in a decade, Jeuveau is manufactured by Evolus and approved by the FDA to smooth away frown lines and create a refreshed, more youthful look.

Juveau™ Before and After

Jeuveau™ vs. Botox®: how is Jeuveau different

Like BOTOX®, Jeuveau is used to temporarily paralyze the underlying facial muscles in the face, creating a smoother look and alleviating frown lines, and results last approximately three months. Jeuveau offers several advantages, and is quickly becoming the most requested alternative to BOTOX® because:

  • Smooths lines and wrinkles like BOTOX®, at less cost.
  • May be more effective if BOTOX® is no longer achieving results.
  • May act more quickly than BOTOX®, and lasts longer for some people

As with BOTOX®, Jeuveau requires upkeep in order for the results to last long-term. The decreased price of this particular injectable treatment may therefore make Jeuveau more accessible to many people who want to retain a more youthful look, or ward off the development of lines and wrinkles.

How does Jeuveau™ work ?

Jeuveau™ prevents your nerves from telling your facial muscles to flex.1 The result? In clinical trials, Jeuveau™ was shown to temporarily improve the appearance of moderate to severe frown lines.1 In 2 long-term safety studies, patients received an average of 3 treatments over the course of 1 year.

What is a Jeuveau™ session like?

If it’s your first time getting a treatment, you may be a little nervous. And that’s okay! Localized pain, infection, inflammation, tenderness, swelling, erythema, and/or bleeding/bruising may be associated with the injection.

What are the results can be expected of Jeuveau™?

In our 2 major clinical trials, when we checked at the 30-day mark, 67.5% of patients in 1 study and 70.4% of subjects in a second study were responders defined as a 2-point composite improvement agreed upon by physician and patient.

Related resources

See all blogs

Botox® Cosmetic Dermatology

Botox®, Dysport, Xeomin, or Jeuveau: Are Neurotoxins Really That Different?

July 13, 2026

It’s easy to get overwhelmed by all the neurotoxin options out there. Botox® used to be the most common wrinkle relaxer, but now dermatologists offer several Botox® alternatives that are...

Skin Care

Is “Glass Skin” Good or Bad?

January 26, 2026

The Trend Has Lots of Benefits, But May Require Adjustments for Certain Skin Types. Here’s How to Achieve it Safely. While scrolling through TikTok, it’s likely you’ve seen lots of...

Toxins Fillers GLP-1

Fixing “Ozempic Face”: Addressing Facial Volume Loss the Healthy Way

December 29, 2025

From national news segments to quick TikTok hits, you’ve likely been flooded with recent content about “Ozempic face,” a term used to describe facial changes that follow rapid weight loss...